Cyclin D1 anticorps (C-Term) (HRP)
-
- Antigène Voir toutes Cyclin D1 (CCND1) Anticorps
- Cyclin D1 (CCND1)
-
Épitope
- AA 211-241, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cyclin D1 est conjugé à/à la HRP
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- CCND1-Y226 (CCND1, BCL1, PRAD1, G1/S-specific cyclin-D1, B Cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene) (Azide free) (HRP)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- CCND1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 211-241 amino acids from the C-terminal region of human CCND1.
- Isotype
- IgG
- Top Product
- Discover our top product CCND1 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2. No preservative added (Azide free).
- Agent conservateur
- Without preservative
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- Cyclin D1 (CCND1)
- Autre désignation
- CCND1 (CCND1 Produits)
- Synonymes
- anticorps BCL1, anticorps D11S287E, anticorps PRAD1, anticorps U21B31, anticorps AI327039, anticorps CycD1, anticorps Cyl-1, anticorps bcl-1, anticorps cD1, anticorps cb161, anticorps cycd1, anticorps etID37810.7, anticorps fb52e01, anticorps fc45c08, anticorps fc83a12, anticorps id:ibd1198, anticorps wu:fb52e01, anticorps wu:fc45c08, anticorps wu:fc83a12, anticorps ccnd1b, anticorps prad1, anticorps ccnd1, anticorps ccnd1a, anticorps bcl1, anticorps d11s287e, anticorps u21b31, anticorps CCND1, anticorps cyclin D1, anticorps cyclin D1 S homeolog, anticorps cyclin D1 L homeolog, anticorps CCND1, anticorps Ccnd1, anticorps ccnd1, anticorps ccnd1.S, anticorps ccnd1.L
- NCBI Accession
- NP_444284
- UniProt
- P24385
- Pathways
- Signalisation PI3K-Akt, Cycle Cellulaire, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
-